General Information
Revision date
2020-08-26
Product name
LAKALO PRIM
Icons in SDS
Company Information
company name
ASTRAL
e-mail address of the competent person responsible for the Safety Data Sheet
astral.tn@akzonobel.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS]]
CLP CLASSIFICATION
Not classified. Ingredients of unknown : 0% toxicity
Ingredients of unknown ecotoxicity
0% See Section 11 for more detailed information on health effects and symptoms.
Signal word
Warning
Hazard statements
H317 - May cause an allergic skin reaction.
Precautionary statements
General : P102 - Keep out of reach of children. P101 - If medical advice is needed, have product container or label at hand.
Prevention
P262 - Do not get in eyes, on skin, or on clothing.
Response
P312 - Call a POISON CENTER or doctor/physician if you feel unwell.
Storage
Not applicable.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national or international regulations.
Hazardous Ingredients
methylisothiazolinone 1,2-benzisothiazol-3(2H)-one C(M)IT/MIT(3:1)
Supplemental label elements
Not applicable. elements
Special packaging requirements
Containers to be fitted Not applicable. with child-resistant fastenings
Tactile warning of danger
Not applicable.
2.3 Other hazards
Substance meets the criteria for PBT according to Regulation (EC) No. 1907/2006, Annex XIII Substance meets the criteria for vPvB according to Regulation (EC) No. 1907/2006, Annex XIII
